OL-047 Long-term therapy with adefovir dipivoxil for HBeAg positive chronic hepatitis B: results from 144 weeks adefovir dipivoxil treatment

J.You; L.Zhuang; H.Y.Chen; X.Feng; L.Kong; H.Lei; Y.L.Ma; Y.L.Li; W.B.Yang; J.H.Huang; S.M.Yan; Y.H.Che; Q.Q.Wang; L.Chen

首页> 外文期刊>International journal of infectious diseases : >OL-047 Long-term therapy with adefovir dipivoxil for HBeAg positive chronic hepatitis B: results from 144 weeks adefovir dipivoxil treatment

【24h】

OL-047 Long-term therapy with adefovir dipivoxil for HBeAg positive chronic hepatitis B: results from 144 weeks adefovir dipivoxil treatment

机译：OL-047阿德福韦酯对HBeAg阳性慢性乙型肝炎的长期治疗：144周阿德福韦酯治疗的结果

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《International journal of infectious diseases :》 |2011年第1期|共1页
作者
J.You; L.Zhuang; H.Y.Chen; X.Feng; L.Kong; H.Lei; Y.L.Ma; Y.L.Li; W.B.Yang; J.H.Huang; S.M.Yan; Y.H.Che; Q.Q.Wang; L.Chen;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类传染病;
关键词

相似文献

外文文献
中文文献
专利

1. Long-term therapy with adefovir dipivoxil for HBeAg positive chronic hepatitis B patients with various baseline biochemical levels: Results from 4 years adefovir dipivoxil treatment [J] . L. Zhuang, J. You, L. Kong, International journal of infectious diseases : . 2014,第Supplementa1期

机译：阿德福韦酯对具有不同基线生化水平的HBeAg阳性慢性乙型肝炎患者的长期治疗：阿德福韦酯4年治疗的结果
2. Efficacy and safety of telbivudine plus adefovir dipivoxil combination therapy and entecavir monotherapy for HBeAg-positive chronic hepatitis B patients with resistance to adefovir dipivoxil [J] . LuJ.-J., LiuK., MaY.-J., Journal of viral hepatitis. . 2013,第Suppla1期

机译：替比夫定联合阿德福韦酯联合恩替卡韦单药治疗HBeAg阳性慢性乙型肝炎对阿德福韦酯耐药的疗效和安全性
3. 96 weeks combination of adefovir dipivoxil plus emtricitabine vs. adefovir dipivoxil monotherapy in the treatment of chronic hepatitis B. [J] . Hui CK, Zhang HY, Bowden S, Journal of Hepatology: The Journal of the European Association for the Study of the Liver . 2008,第5期

机译：阿德福韦酯联合恩曲他滨与阿德福韦酯联合应用96周联合治疗慢性乙型肝炎。
4. Adefovir dipivoxil for the treatment of chronic hepatitis B infection and in vitro evaluation of hte cross-resistance profiles of lamivudine,famciclovir and adefovir [C] . X Xiong, A Murray, H Yang, Second workshop related to HIV/AIDS in China . 1999

机译：阿德福韦酯对慢性乙型肝炎感染的治疗以及拉米夫定，泛昔洛韦和阿德福韦的交叉耐药性的体外评估
5. Chronic Hepatitis C and HIV Treatment Outcomes among Women Who Initiate Antiretroviral Therapy [D] . Willis, Sarah J. 2018

机译：开始抗逆转录病毒疗法治疗的女性中的慢性丙型肝炎和艾滋病毒治疗结果
6. A randomized multi-central controlled study of patients with hepatitis B e antigen-positive chronic hepatitis B treated by adefovir dipivoxil or adefovir dipivoxil plus bicyclol [O] . Wen Xie, Guangfeng Shi, Hongfei Zhang, -1

机译：阿德福韦酯或阿德福韦酯联合双环醇治疗乙型肝炎e抗原阳性慢性乙型肝炎患者的随机多中心对照研究
7. OL-047 Long-term therapy with adefovir dipivoxil for HBeAg positive chronic hepatitis B: results from 144 weeks adefovir dipivoxil treatment [O] . You J., Zhuang L., Chen H.Y., 2011

机译：OL-047阿德福韦酯对HBeAg阳性慢性乙型肝炎的长期治疗：144周阿德福韦酯治疗的结果

OL-047 Long-term therapy with adefovir dipivoxil for HBeAg positive chronic hepatitis B: results from 144 weeks adefovir dipivoxil treatment

著录项

相似文献

相关主题

期刊订阅